Zoetis | ZTS - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
AbbVie USD 9.39B 4.16B 2026-03
Align Technology USD 1.06B 35.07M 2026-03
Bayer EUR 6.67B 774M 2025-12
Bristol-Myers Squibb USD 9.57B 635M 2026-03
Charles River Laboratories USD 191.83M 21.94M 2026-03
Coherus Biosciences USD 88.88M 14.47M 2025-12
Dentsply International USD 190M 136M 2026-03
Eli Lilly USD 5.28B 1.99B 2026-03
Henry Schein USD 138M 18M 2026-03
Idexx Laboratories USD 200.53M 20.46M 2026-03
Illumina USD 1.42B 368M 2025-12
IQVIA Holdings USD 1.95B 33M 2026-03
J&J USD 21.69B 1.98B 2026-03
Laboratory Of America USD 981.1M 448.8M 2026-03
Merck USD 5.33B 9.24B 2026-03
Neogen USD 159.9M 14.56M 2025-12
Pacira USD 144.31M 14.24M 2026-03
Perrigo USD 531.6M 99.5M 2025-12
Pfizer USD 1.7B 561M 2026-03
Phibro Animal Health USD 54.93M 557K 2026-03
Quest Diagnostics USD 393M 27M 2026-03
Sanofi EUR 7.66B 1.25B 2025-12
Sanofi EUR 5.54B 2.11B 2026-03
Zoetis USD 1.94B 369M 2026-03